Bio-Rad Laboratories, Inc.
BIO
Rangering i aksjer
#2162
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Aksjekurs
$355.65
Markedsverdi
$9.51B
Endring (1 dag)
1.02%
Endring (1 år)
10.48%
Land
US
Handel Bio-Rad Laboratories, Inc. (BIO)
Kategori
Healthcare
Antall utestående aksjer for Bio-Rad Laboratories, Inc. (BIO)
Antall utestående aksjer per June 2026: 26.75M
Ifølge Bio-Rad Laboratories, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 26.75M. Ved slutten av December 2024 hadde selskapet 28.21M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Bio-Rad Laboratories, Inc. (BIO) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 26.75M | -1.90% |
| 2025 | 27.26M | -3.37% |
| 2024 | 28.21M | -3.41% |
| 2023 | 29.21M | -1.93% |
| 2022 | 29.79M | -0.15% |
| 2021 | 29.83M | 0.21% |
| 2020 | 29.77M | -0.25% |
| 2019 | 29.84M | 0.02% |
| 2018 | 29.84M | 0.61% |
| 2017 | 29.66M | 0.73% |
| 2016 | 29.44M | 0.87% |
| 2015 | 29.19M | 1.07% |
| 2014 | 28.88M | 1.01% |
| 2013 | 28.59M | 1.05% |
| 2012 | 28.29M | 0.92% |
| 2011 | 28.03M | 1.32% |
| 2010 | 27.67M | 0.95% |
| 2009 | 27.40M | 1.08% |
| 2008 | 27.11M | 1.48% |
| 2007 | 26.72M | 1.29% |
| 2006 | 26.38M | 1.20% |
| 2005 | 26.06M | 1.32% |
| 2004 | 25.72M | 1.21% |
| 2003 | 25.42M | 1.12% |
| 2002 | 25.13M | 1.97% |
| 2001 | 24.65M | 0.93% |
| 2000 | 24.42M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 1.74B | 6,417.05% |
US
|
|
| 1.28B | 4,693.61% |
IE
|
|
| 383.50M | 1,333.86% |
US
|
|
| 1.48B | 5,424.56% |
US
|
|
| - | - |
DE
|
